VOCLAZIDE M (60+500) TAB

VOCLAZIDE M (60+500) TAB by Voithea Healthcare is an advanced anti-diabetic formulation combining Gliclazide 60mg and Metformin 500mg in a prolonged-release tablet. This powerful dual therapy is designed to optimize blood glucose control in patients with type 2 diabetes by stimulating insulin secretion and enhancing insulin sensitivity.

The sustained-release technology ensures consistent therapeutic levels, minimizing glycemic variability and improving overall treatment outcomes. VOCLAZIDE M (60+500) TAB reflects Voithea Healthcare’s dedication to providing reliable, effective, and patient-focused diabetes management solutions.